Illness perception and self-management behaviours in adults with multimorbidity: a systematic review protocol Authors: Ana Lúcia Junger, Else Saliés Fonseca, Ana Luiza Lima Sousa, Sandro Rogério Rodrigues Batista Published: 2026 ABSTRACT AbstractIntroductionMultimorbidity, characterised by the coexistence of two or more chronic conditions, represents a growing challenge for health systems, adversely affecting quality of life, self-care, treatment adherence and service utilisation. Within the context of self-regulation in health, the Common-Sense Model of Self-Regulation of Health and Illness (CSM) proposes that illness perceptions—such as beliefs about causes, control, consequences, timeline and illness identity—influence health behaviours. Despite consolidated evidence in single-disease contexts, little is known about how these perceptions operate when multiple conditions coexist, particularly due to the need to integrate potentially conflicting representations. To date, no systematic reviews have synthesised these relationships specifically in populations with multimorbidity. This protocol describes the methods for a systematic review aimed at examining how illness perceptions are associated with treatment adherence, self-care and indicators of chronic condition management in adults with multimorbidity.Methods and analysisThis systematic review will be reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines. Observational studies involving adults (≥18 years) with multimorbidity, which assess illness perceptions using validated instruments and report outcomes related to treatment adherence, self-care or self-management behaviours, will be included. The search will be conducted in the PubMed, Scopus, Web of Science, Embase, CINAHL, PsycINFO and LILACS databases, using combinations of descriptors related to illness perception, multimorbidity and health behaviours. Two independent reviewers will conduct study selection, data extraction and methodological quality assessment. The risk of bias will be assessed using the Newcastle-Ottawa Scale, and the overall quality of the evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Where appropriate, meta-analysis will be conducted using measures of association (eg, ORs, relative risk or HRs); otherwise, a structured narrative synthesis will be performed. Subgroup analyses will be conducted when data are available.Ethics and disseminationAs it uses exclusively secondary and published data, this review does not require approval by a research ethics committee. The results will be submitted for publication in a peer-reviewed journal and disseminated at relevant scientific conferences.PROSPERO numberCRD420251266292. STRENGTHS AND LIMITATIONS OF THIS STUDY This protocol follows established methodological standards for systematic reviews, including Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines and prior registration in PROSPERO (International Prospective Register of Systematic Reviews). This protocol follows established methodological standards for systematic reviews, including Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines and prior registration in PROSPERO (International Prospective Register of Systematic Reviews). A comprehensive search strategy will be conducted across multiple databases, complemented by reference screening and citation tracking. A comprehensive search strategy will be conducted across multiple databases, complemented by reference screening and citation tracking. The inclusion of validated instruments to assess illness perception enhances the reliability of the exposure measurement. The inclusion of validated instruments to assess illness perception enhances the reliability of the exposure measurement. Potential heterogeneity in study designs, populations and outcome measures may limit the feasibility of meta-analysis. Potential heterogeneity in study designs, populations and outcome measures may limit the feasibility of meta-analysis. Variability in definitions of multimorbidity and measurement of self-management behaviours across studies may affect the comparability of findings. Variability in definitions of multimorbidity and measurement of self-management behaviours across studies may affect the comparability of findings. Introduction Nowadays, multimorbidity, that is, the coexistence of two or more chronic conditions in the same individual, represents one of the main contemporary challenges for health systems in terms of prevalence, severity and possibility of control.1 According to the European General Practice Research Network, multimorbidity corresponds to the simultaneous presence of various chronic health conditions in the same individual, considering their biopsychosocial interactions and the cumulative impact on daily life, care management and the health system.2 This conception broadens the understanding of the phenomenon, going beyond a simple disease count, by recognising the functional, emotional and social implications of the coexistence of multiple conditions. The prevalence of multimorbidity is estimated to be increasing globally, accompanying population ageing and the epidemiological transition. Data from a recent systematic review show that 37.2% of adults have two or more chronic diseases, a proportion that exceeds 50% among older adults.3 This condition is associated with poorer quality of life, increased risk of hospitalisation, polypharmacy and catastrophic health costs.48 With complex management, care related to multimorbidity demands the administration of multiple therapeutic regimens and the management of varied symptoms and self-care demands, in addition to dealing with potential drug interactions and clinical recommendations, which are sometimes conflicting.9 10 This scenario is intensified by the use of disease-centred guidelines, often inadequate for patients with multiple conditions, as they may result in extensive, poorly coordinated and difficult-to-implement treatment plans.1013 The cumulative application of these recommendations contributes to the so-called treatment burden, which includes numerous and demanding tasks, directly impacting the patient’s ability to manage their conditions.14 15 In this context, psychological and behavioural aspects become determinants for the daily management of health, as they influence how the individual understands and copes with their chronic conditions.16 Among these aspects, illness perception stands out as a theoretical construct widely studied within the Common-Sense Model of Self-Regulation of Health and Illness (CSM), developed by Leventhal and colleagues.1618 The CSM proposes that people form cognitive and emotional representations about their illnesses, which guide coping strategies and health behaviours.16 These representations encompass dimensions such as identity (symptoms and illness label), perceived causes, timeline, consequences, controllability and coherence of the condition.1719 Thus, illness perception guides the self-regulation of care, the process by which the individual interprets their condition, adopts management strategies and monitors their outcomes.20 Evidence shows that more adaptive perceptions, such as beliefs of personal control and confidence in treatment efficacy, are associated with greater adherence, better self-care and better clinical outcomes.21 However, in contexts of multimorbidity, this relationship becomes more complex. The coexistence of multiple conditions can generate conflicting representations, cognitive overload and feelings of ineffectiveness, compromising adherence and integrated care management.22 23 Studies suggest that patients with multimorbidity often face difficulties in prioritising diseases, understanding interactions between treatments and maintaining consistent self-care behaviours.2426 Furthermore, different conditions may have distinct perceived meanings, beliefs and trajectories, requiring the individual to reconcile multiple illness representations simultaneously, a process that may strongly influence both behaviour and health outcomes.2730 Despite the findings, the literature remains fragmented regarding how illness perceptions interact with health behaviours in populations with multiple chronic conditions.31 Furthermore, no systematic reviews specifically dedicated to synthesising these relationships in the context of multimorbidity have been identified, highlighting a significant gap in current scientific production. Given this scientific gap, the present protocol proposes the conduct of a systematic review aiming to synthesise the available evidence on how patient illness perception relates to treatment adherence, self-care and the management of multiple chronic conditions. Thus, it is intended to contribute to the advancement of knowledge about self-regulation processes in care within multimorbidity contexts. Methods Protocol and registration This protocol is reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines, with the completed checklist provided in online supplementary material 1. This protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under the number CRD420251266292. The PROSPERO record was subsequently updated to reflect methodological refinements made during protocol development, ensuring transparency and consistency with the current protocol. Any important future amendments will be documented in the PROSPERO record and reported in the final review. Review question and outcomes The review question was structured according to the PECO framework as follows: population (P), consisting of adults with multimorbidity (two or more chronic conditions) of both sexes; exposure (E), individuals with illness perception assessed by validated instruments or dimensions of the CSM; comparison (C), individuals with different levels or profiles of illness perception or, where applicable, groups without assessment of this perception and outcomes (O), indicators of treatment adherence, self-care behaviours and management of chronic conditions. The present study aims to investigate the association between illness perception and health-related behaviours in individuals with multimorbidity, specifically treatment adherence, self-care and indicators of chronic condition management. These outcomes will be analysed separately. In addition, subgroup and exploratory analyses will be conducted, when data are available, to examine the influence of specific dimensions of illness perception (eg, identity, perceived cause, timeline, consequences, personal control, treatment control, illness coherence and emotional responses), as well as potential modifiers of this relationship, including age, sex, number of chronic conditions, treatment complexity and the presence of depressive or anxiety symptoms. Eligibility criteria Eligibility criteria were defined a priori based on the PECO framework. Studies will be included if they meet the following criteria: (1) observational studies; (2) adults (≥18 years) with multimorbidity, defined as the presence of two or more chronic conditions. Studies will be considered eligible if they explicitly define multimorbidity or clearly report the coexistence of at least two chronic conditions. No restriction will be applied regarding specific disease combinations, provided that conditions are described as chronic and require ongoing management; (3) assessment of illness perception using validated instruments such as the Illness Perception Questionnaire (IPQ), IPQ-Revised, Brief IPQ, MULTIPleS or equivalent measures assessing cognitive and/or emotional illness representations based on the CSM; (4) measures of treatment adherence, self-care or self-management behaviours, assessed using validated instruments or clearly described objective or subjective methods. When reported, clinical indicators related to chronic condition management (eg, disease control measures) will also be considered and (5) investigation of the relationship, association, correlation, mediation or moderation between illness perception and at least one of the outcomes of interest. The following will be excluded: (1) clinical trials, experimental studies, case reports, case series and qualitative studies without a quantitative component; (2) studies with populations without multimorbidity; (3) studies that assess illness perception but do not include adherence, self-care or management outcomes; (4) exclusively paediatric studies and (5) non-original publications (editorials, commentaries, letters to the editor, reviews and protocols). Search strategy The search was performed in February 2026 in the PubMed (National Library of Medicine, USA), Scopus, Web of Science, Embase, CINAHL, PsycINFO and LILACS databases. The terms will be searched in a standardised manner across the databases, using the following combinations: #1 “Illness Perception” OR “Disease Perception” OR “Cognitive Representation” OR “Illness Cognitions” OR “Illness Representations” OR “Common-Sense Model” OR “Self-Regulation Model” OR “Leventhal Model” #2 Multimorbidity OR “Multiple Chronic Conditions” OR “Comorbidity” OR “Chronic Disease” OR “Chronic Conditions” OR “Long-Term Conditions” #3 Adherence OR “Treatment Adherence” OR “Medication Adherence” OR Compliance OR “Self-care” OR “Self-Management” OR “Disease Management” OR “Health Behavior” #4 = #1 AND #2 AND #3 The complete strategy applied in each database will be presented in online supplementary material 2, including Boolean operators, filters and search fields. In addition to the electronic database search, complementary manual search procedures will be undertaken to maximise study identification. Grey literature will not be systematically searched. No date limit will be applied, and the search will be restricted to English, Portuguese and Spanish. Reviewer training The authors responsible for the eligibility and study selection stages (ALJ and ESF) will undergo prior training to ensure consistent application of the inclusion and exclusion criteria. This training will include a pilot test with the first 100 records to align interpretations and standardise decisions. The reviewers will also be trained to use the risk of bias assessment instruments adopted in the review. Study selection and review process After performing the search strategy, duplicate articles will be removed using EndNote software. All screening and selection steps will be conducted with the support of EndNote and Rayyan software.32 Subsequently, two reviewers (ALJ and ESF) will independently screen titles and abstracts in Rayyan, excluding studies that do not meet the inclusion criteria. Potentially relevant articles will then be assessed in full text to confirm eligibility. Any discrepancies regarding study eligibility will be resolved by a third reviewer (ALLS). In addition, the reference lists of included studies will be manually examined, and citation tracking will be performed to identify additional publications not retrieved in the database searches. The study selection process will be presented using a PRISMA flow diagram (available in online supplementary material 3). Data extraction Data extraction from the included studies will be performed by two independent reviewers (ALJ and ESF). For this process, a standardised form developed by the authors will be used. The following study characteristics and variables will be extracted: authors, year of publication, country, study design, characteristics of the investigated population (age range, sample size, sex and chronic conditions included), instruments used to assess illness perception, dimensions assessed, outcomes related to treatment adherence, self-care behaviours and clinical indicators of multimorbidity management, as well as the main associations and adjustment variables presented by the studies. The proposed data extraction table for this review is presented in table 1. Table 1Template for the data extraction tableAuthor, year, countryStudy designPopulation (age range, N, sex and chronic conditions)InstrumentsDimensions assessedOutcomesResults and associationsAdjustment variables Template for the data extraction table Differences between reviewers during extraction will be resolved by a third reviewer (ALLS). When necessary, the authors of the studies will be contacted to obtain missing data or additional information. Quality assessment and risk of bias The risk of bias of the included studies will be assessed by two independent reviewers using the Newcastle-Ottawa Scale).33 The scale will be applied in an adapted form according to the design of the included studies. The overall quality of the evidence will be assessed, where appropriate, using the GRADE34 approach, considering factors such as risk of bias, inconsistency, indirectness, imprecision and publication bias. Disagreements between reviewers will be resolved through discussion or, when necessary, by consultation with a third reviewer. Evidence synthesis and statistical analysis If the extracted data are sufficiently homogeneous in terms of study design, exposure assessment, outcome measures and reported measures of association, a meta-analysis will be conducted. Pooled estimates will be calculated using comparable measures of association reported by the included studies, according to the type of data available, focusing on the relationship between illness perception and the outcomes of interest. Statistical heterogeneity will be assessed using the I² statistic, considering low (25%), moderate (50%) and high (75%) heterogeneity. If meta-analysis is not feasible due to substantial heterogeneity in study designs, populations, exposures or outcome measures, a narrative synthesis will be conducted. This synthesis will follow a structured approach, summarising findings according to key study characteristics, types of outcomes and the direction and strength of reported associations. Where sufficient studies are available, potential publication bias and selective reporting across studies will be assessed and considered in the interpretation of the findings. Where possible, subgroup analyses will be performed, considering variables such as clinical characteristics of the population (number of chronic conditions, type of condition and severity), as well as sociodemographic aspects (sex, age group, ethnic groups and educational level). Discussion This systematic review protocol aims to address an important gap in the literature by synthesising evidence on the association between illness perception and health-related behaviours in individuals with multimorbidity. Although illness perception has been associated with self-care behaviours, treatment adherence and healthcare use in chronic conditions,3537 research has predominantly focused on single or non-specific diseases.3842 To our knowledge, no systematic reviews specifically synthesising the association between illness perception and health-related behaviours in populations with multimorbidity have been identified. The available evidence on this topic remains limited and fragmented, consisting mainly of individual observational studies.4347 Given the complexity of multimorbidity, including competing treatment demands and overlapping symptomatology, understanding how individuals interpret and respond to their conditions may contribute to a more comprehensive understanding of self-management behaviours in this population. This protocol was developed in accordance with established methodological standards for systematic reviews, including prior registration and the use of explicit eligibility criteria, duplicate screening and structured risk-of-bias assessment. These methodological procedures are expected to enhance the transparency and reproducibility of the review. Nevertheless, some anticipated limitations should be considered. Variability in the definition and operationalisation of multimorbidity across studies may affect the comparability of findings. Differences in the instruments used to assess illness perception and in the measurement of adherence, self-care and self-management behaviours may also introduce substantial heterogeneity, potentially limiting the feasibility of quantitative synthesis. In addition, the exclusion of publications in languages other than English, Portuguese and Spanish, as well as the absence of a systematic grey literature search, may have limited the identification of some relevant studies. Despite these limitations, this review is expected to provide a comprehensive synthesis of the available evidence and to clarify how illness perception may be associated with key health-related behaviours in individuals living with multimorbidity. The findings may inform future research and support the development of more tailored and context-sensitive approaches to multimorbidity care. Supplementary material